Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL820 in advanced GIST
NCT00570635Phase 2Completed
- Sponsor
- Exelixis, Inc.
- Start
- Dec 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xl820 in gastrointestinal stromal tumor (GIST), sponsored by Exelixis, Inc.. Started Dec 2007; status: completed.
02
Drugs
xl820
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00570635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570635.